Seller record · Telehealth service

VevaRX

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The answers and terms refer only to licensed compounding pharmacies and licensed third-party pharmacies. 2 more criteria also fail; see the table below.

At a glance

VevaRXTelehealth service

4/8criteria passed
Price
Compounded semaglutide $120 a month, or about $47 a month on a 12-month plan ($564); tirzepatide $189 a month
Sells
compounded semaglutide, compounded tirzepatide, sermorelin, and 4 more
FDA letters
None on file
Visit VevaRXSee all eight dispositions

Telehealth service. Passes 4 of 8 criteria. 1 not verified, counting neither way. Recorded against Standard v1.1.

A telehealth weight loss service aimed at women, selling compounded semaglutide and tirzepatide on monthly to 12-month plans beside sermorelin, NAD+, glutathione and PT-141. Its own pages print several different price sets, and it gives no postal address and names no pharmacy.

Operating entity VevaRx LLC

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSVevaRX's FAQ; VevaRX's our program page; VevaRX's privacy policy
S2Prescription gatingNOT VERIFIEDVevaRX's website; VevaRX's semaglutide product page; VevaRX's vx terms and conditions
S3Pharmacy identificationFAILVevaRX's FAQ; VevaRX's vx terms and conditions
S4Compounding disclosurePASSVevaRX's semaglutide product page; VevaRX's tirzepatide product page; VevaRX's website
S5Analytical documentationFAILVevaRX's semaglutide product page; VevaRX's FAQ; VevaRX's vx terms and conditions
S6Business addressFAILVevaRX's contact page; VevaRX's vx terms and conditions; VevaRX's privacy policy
S7Price disclosurePASSVevaRX's semaglutide product page; VevaRX's tirzepatide product page; VevaRX's our program page; VevaRX's vx terms and conditions
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed healthcare provider reviews each health assessment and prescribes only when treatment is appropriate, with a phone or video visit where a state requires one. The privacy policy names TelegraMD as the telehealth platform its providers use.Source: VevaRX's FAQ; VevaRX's our program page; VevaRX's privacy policy.
S2NOT VERIFIEDWhether payment is taken before the medical questions did not resolve, because the home page lists a free health assessment first and the choice of a treatment second, while each product page shows plan buttons marked with the amount due today and says the price is locked in before the patient intake, and the terms say an order is processed once the medical intake is submitted. The check is open.Source: VevaRX's website; VevaRX's semaglutide product page; VevaRX's vx terms and conditions.
S3FAILNo filling pharmacy is named. The answers and terms refer only to licensed compounding pharmacies and licensed third-party pharmacies.Source: VevaRX's FAQ; VevaRX's vx terms and conditions.
S4PASSEvery product page states that compounded medications are not FDA-approved and that the FDA does not verify their safety, effectiveness or quality, and the answers say the compounded products are not approved by the FDA.Source: VevaRX's semaglutide product page; VevaRX's tirzepatide product page; VevaRX's website.
S5FAILNo certificate of analysis or lot document is published on the product pages, in the answers or in the terms.Source: VevaRX's semaglutide product page; VevaRX's FAQ; VevaRX's vx terms and conditions.
S6FAILNo postal address appears on the contact page, in the footer, in the terms or in the privacy policy, which name VevaRx LLC and give only an email address and a text number.Source: VevaRX's contact page; VevaRX's vx terms and conditions; VevaRX's privacy policy.
S7PASSCompounded semaglutide costs $120 month to month, or $267 for 3 months, $430 for 6 months and $564 for 12 months, about $47 a month; compounded tirzepatide costs $189 month to month, or $447, $767 and $1,044, about $87 a month, with the provider visit, medication and shipping included. Sermorelin and NAD+ cost $399 for 3 months, glutathione $349 for 3 months, the NAD+ and glutathione stack $699 and PT-141 $247 a month or $598 for 3 months. The program page and answers instead give a starting price of $183 a month, the glutathione plan notes give $267, and the terms list a GLP-1 package at $199 for the first month, then $299, and a GLP-1 plus GIP package at $349 for the first month, then $399.Source: VevaRX's semaglutide product page; VevaRX's tirzepatide product page; VevaRX's our program page; VevaRX's vx terms and conditions.
S8PASSNo FDA warning letter names VevaRX or VevaRx LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, sermorelin, NAD+, glutathione, NAD+ and glutathione stack, PT-141.

Other sellers of the same products

Who sells semaglutideWho sells tirzepatideWho sells sermorelinWho sells NAD+Who sells glutathioneWho sells PT-141

Visit VevaRX

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.